Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Tax Provisions (2016 - 2026)

Usana Health Sciences has reported Tax Provisions over the past 17 years, most recently at $8.5 million for Q2 2026.

  • Quarterly Tax Provisions rose 14.19% to $8.5 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $31.1 million through Apr 2026, changed 0.19% year-over-year, with the annual reading at $30.0 million for FY2026, 12.37% down from the prior year.
  • Tax Provisions was $8.5 million for Q2 2026 at Usana Health Sciences, up from $5.8 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $15.8 million in Q1 2022 and troughed at $5.8 million in Q1 2026.
  • The 5-year median for Tax Provisions is $9.4 million (2023), against an average of $9.3 million.
  • Year-over-year, Tax Provisions plummeted 39.61% in 2024 and then rose 14.19% in 2026.
  • A 5-year view of Tax Provisions shows it stood at $10.0 million in 2022, then decreased by 1.62% to $9.8 million in 2023, then plummeted by 39.61% to $5.9 million in 2024, then surged by 42.24% to $8.5 million in 2025, then increased by 0.59% to $8.5 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Tax Provisions are $8.5 million (Q2 2026), $5.8 million (Q1 2026), and $8.5 million (Q3 2025).